CHIR-200131

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCHIR-200131
Drug Alias Nametyrosine kinase inhibitor (Chiron)CHIR-200131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChiron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron Corp
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A